Loading…
Grifols signed a 15-year agreement with Canadian Blood Services to manufacture immunoglobulin from Canadian plasma at its Montreal fractionation facility, aiming to increase Canada's Ig self-sufficiency from 15% to 50%. The deal includes an incremental 2.4 million grams of Ig annually.